ATOPIC ECZEMA/DERMATITIS (NON-SPECIFIC)

Clinical trials for ATOPIC ECZEMA/DERMATITIS (NON-SPECIFIC) explained in plain language.

Never miss a new study

Get alerted when new ATOPIC ECZEMA/DERMATITIS (NON-SPECIFIC) trials appear

Sign up with your email to follow new studies for ATOPIC ECZEMA/DERMATITIS (NON-SPECIFIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human trial begins for new eczema drug candidate

Disease control Recruiting now

This is the first study in humans to test the safety and how the body processes a new drug called ATTO-3712. It will involve healthy adults and people with moderate-to-severe atopic dermatitis (eczema). Researchers will give increasing doses to see how well it's tolerated and how…

Matched conditions: ATOPIC ECZEMA/DERMATITIS (NON-SPECIFIC)

Phase: PHASE1 • Sponsor: Attovia Therapeutics Inc • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

ATOPIC ECZEMA/DERMATITIS (NON-SPECIFIC)

Get alerted when new ATOPIC ECZEMA/DERMATITIS (NON-SPECIFIC) trials appear

First human trial begins for new eczema drug candidate